US OptionsDetailed Quotes
TGTX250502P36500
- 0.75
- 0.000.00%
15min DelayTrading Apr 24 14:58 ET
0.00High0.00Low
0.00Open0.75Pre Close0 Volume31 Open Interest36.50Strike Price0.00Turnover283.59%IV20.59%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.75Extrinsic Value100Contract SizeAmericanOptions Type-0.1390Delta0.0230Gamma60.03Leverage Ratio-0.4997Theta-0.0004Rho-8.34Eff Leverage0.0075Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet